Trial Profile
A study to evaluate responders to liraglutide treatment for diabetes and weight loss
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Mar 2016 New trial record